Open day on Biotechnology - 5 November 2010
In the framework of the ongoing work of the High-Level Expert Group on Key Enabling Technologies, this Open Day was organised by the Working Group on Biotechnologies in order to consult a broad stakeholder audience on the needs and challenges of the sector, contributing to the development of appropriate policy measures to promote the industrial deployment of KETs in Europe.
At variance with other technologies, Biotechnology is a well established concept for about one century. However, the constant evolution of biological sciences combined with new modern technologies allows Biotechnology to make use of biological systems and processes to manufacture useful products and to provide services in all global society challenges such as environment, energy, food, or health. The development of Biotechnology seems to be one of the key players in the short to medium term evolution of Europe and the rest of the world. This is the reason why it has been considered a “Key Enabling Technology” by the European Commission.
In order to set up a strategy for the deployment of KETs in Europe, and specifically to foster European leadership in Biotechnology, it seemed necessary to bring together the main actors to discuss aspects such as research challenges, strengths and gaps, how to make Europe more competitive, innovation, how to shorten time to market, financing or employment consequences among others.
The Open Day on Biotechnology was organised with an agenda that addressed all the previous issues mentioned above, with the aim to contribute to assess the European competitive situation and to bring arguments that help developing an appropriate and detailed strategy and to define possible policy measures directed to ensure an effective deployment of KET Biotechnology in Europe.
The Open Day in Biotechnology included the participation of the essential partners that should play the major role in the industrial deployment of Biotechnology in Europe, such as representatives from industry (energy, enzymes, catalysis, food, health, tensoactives, plastics and materials, etc.), investors, European Commission representatives, Member States representatives, European Bioclusters representatives, academics and researchers, users organisations, public authorities, among others.
Agenda [12 KB]
Presentations, which have been approved by the authors for the publication.
Luigi Ambrosio [2 MB]
Wim Soetaert [2 MB]
John Claxton [783 KB]
The views expressed are those of the writer and may not be regarded as stating an official position of the European Commission.
Clements van Blitterswijk [11 MB]
Manfred Kircher [3 MB]
Patrick Boisseau [2 MB]
Andrè Kolterman [3 MB]
Camille Burel [2 MB]
Gunther Festel [159 KB]
Giulia Del Brenna [537 KB]